EU-UK Trade and Cooperation Agreement: Implications for Life Sciences Companies

Published date04 March 2021
Subject MatterMedical Devices,Life Sciences,Manufacturers,EU,Clinical Trials,Trade Agreements,UK,Data Privacy,UK Brexit,Pharmaceutical Industry,Marketing Authorization Application
AuthorFrances Stocks Allen,Oliver Mobasser,Sara Patel,Eveline Van Keymeulen
Law FirmLatham & Watkins LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT